Physicochemical explanation of peptide binding to HLA‐A*0201 major histocompatibility complex: A three‐dimensional quantitative structure‐activity relationship study
- 14 June 2002
- journal article
- research article
- Published by Wiley in Proteins-Structure Function and Bioinformatics
- Vol. 48 (3), 505-518
- https://doi.org/10.1002/prot.10154
Abstract
A three-dimensional quantitative structure-activity relationship method for the prediction of peptide binding affinities to the MHC class I molecule HLA-A*0201 was developed by applying the CoMSIA technique on a set of 266 peptides. To increase the self consistency of the initial CoMSIA model, the poorly predicted peptides were excluded from the training set in a stepwise manner and then included in the study as a test set. The final model, based on 236 peptides and considering the steric, electrostatic, hydrophobic, hydrogen bond donor, and hydrogen bond acceptor fields, had q2 = 0.683 and r2 = 0.891. The stability of this model was proven by cross-validations in two and five groups and by a bootstrap analysis of the non-cross-validated model. The residuals between the experimental pIC50 (-logIC50) values and those calculated by “leave-one-out” cross-validation were analyzed. According to the best model, 63.2% of the peptides were predicted with |residuals| ≤ 0.5 log unit; 29.3% with 1.0 ≤ |residuals| < 0.5; and 7.5% with |residuals| > 1.0 log unit. The mean |residual| value was 0.489. The coefficient contour maps identify the physicochemical property requirements at each position in the peptide molecule and suggest amino acid sequences for high-affinity binding to the HLA-A*0201 molecule. Proteins 2002;48:505–518.Keywords
This publication has 67 references indexed in Scilit:
- Customized versus universal scoring functions: application to class I MHC–peptide binding free energy predictionsBioorganic & Medicinal Chemistry Letters, 2001
- Nonapeptide Analogues Containing (R)-3-Hydroxybutanoate and β-Homoalanine Oligomers: Synthesis and Binding Affinity to a Class I Major Histocompatibility Complex ProteinJournal of Medicinal Chemistry, 1999
- Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions.Journal of Clinical Investigation, 1998
- Two complementary methods for predicting peptides binding major histocompatibility complex moleculesJournal of Molecular Biology, 1997
- Differences and similarities in the A2.1‐restricted cytotoxic T cell repertoire in humans and human leukocyte antigen‐transgenic miceEuropean Journal of Immunology, 1996
- Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assaysMolecular Immunology, 1994
- Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 moleculesCell, 1993
- Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC moleculesNature, 1991
- Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 Å resolutionJournal of Molecular Biology, 1991
- Peptide quantitative structure-activity relationships, a multivariate approachJournal of Medicinal Chemistry, 1987